More information has been released about the treatment and what its advertised side effects are. It’s pretty frightening, and once added to the growing amount of patient feedback from clinical trials, it starts to become clear why the DEA is dragging its feet on their ruling for Epidiolex.Read More
If even one child is denied this life-altering medication based not just on bullshit laws that we’ve been fighting for decades, but for ever-increasing corporate revenues, then it’ll be easy to point to the real criminals.Read More
In the wake of the June 25th decision by the Federal Drug Administration to approve a cannabis-based CBD-rich epilepsy medication from GW Pharma, a new lawsuit has been filed by a medical marijuana user against the federal government.
The plaintiff is essentially calling the FDA as her first witness and this has the federal government tiptoeing through a minefield of their own making.Read More
The FDA’s Center for Drug Evaluation and Research has approved the legal use of CBD for patients ages 2 and up who suffer from very specific conditions: Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), two severe forms of childhood-onset epilepsy. With so much public support in the US for cannabis legalization – not just CBD legalization – the time is right for a major overhaul.Read More